[Chemotherapy and immunosuppression in patients with hepatitis B or C].
作者信息
Sitruk V, Fain O, Gordien E, Ganne-Carrié N, Deny P, Beaugrand M, Trinchet J C
机构信息
Service d'Hépato-Gastroentérologie, Hôpital Jean-Verdier, Bondy Cedex, France.
出版信息
Gastroenterol Clin Biol. 2001 Nov;25(11):1002-7.
PMID:11845054
Abstract
摘要
相似文献
1
[Chemotherapy and immunosuppression in patients with hepatitis B or C].
Gastroenterol Clin Biol. 2001 Nov;25(11):1002-7.
2
Prevention of hepatitis B reactivation with lamivudine in hepatitis B virus carriers with hematologic malignancies treated with chemotherapy--a prospective case series.
Am J Hematol. 2005 Nov;80(3):197-203. doi: 10.1002/ajh.20471.
3
Hepatitis B virus reactivation in patients receiving chemotherapy for cancer treatment: role of Lamivudine prophylaxis.
Cancer Invest. 2006 Aug-Sep;24(5):548-52. doi: 10.1080/07357900600815232.
4
[Effect of lamivudine for hepatitis B virus reactivation in blood cancer patients undergoing immunosuppressive chemotherapy].
Fukuoka Igaku Zasshi. 2004 Oct;95(10):274-9.
5
[Reactivation in immunosuppression. Complicated hepatitis comeback].
MMW Fortschr Med. 2004 Sep 23;146(39):5-6.
6
Lamivudine for chemotherapy-induced reactivation of HBV: prophylaxis or treatment?
Am J Gastroenterol. 2002 May;97(5):1268-9. doi: 10.1111/j.1572-0241.2002.05722.x.
7
[The prevention of hepatitis B virus (HBV) reactivation after cytotoxic or immunosuppressive therapy].
Zhonghua Nei Ke Za Zhi. 2008 Oct;47(10):796-7.
8
[Prevention and management of hepatitis B virus reactivation during anticancer or immunosuppressive therapy].
Nihon Rinsho. 2011 May;69 Suppl 4:520-5.
9
Hepatitis B virus reactivation following immunosuppressive therapy: guidelines for prevention and management.
Intern Med J. 2007 Oct;37(10):705-12. doi: 10.1111/j.1445-5994.2007.01479.x.
10
Hepatitis B virus reactivation after cytotoxic chemotherapy: the disease and its prevention.
Clin Gastroenterol Hepatol. 2006 Sep;4(9):1076-81. doi: 10.1016/j.cgh.2006.05.027. Epub 2006 Jul 24.
Zotero 插件